JP2021016625A - 生体内物質の可視化装置 - Google Patents
生体内物質の可視化装置 Download PDFInfo
- Publication number
- JP2021016625A JP2021016625A JP2019134646A JP2019134646A JP2021016625A JP 2021016625 A JP2021016625 A JP 2021016625A JP 2019134646 A JP2019134646 A JP 2019134646A JP 2019134646 A JP2019134646 A JP 2019134646A JP 2021016625 A JP2021016625 A JP 2021016625A
- Authority
- JP
- Japan
- Prior art keywords
- substance
- living body
- visualization device
- electrode bands
- movement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims abstract description 73
- 238000001727 in vivo Methods 0.000 title claims abstract description 19
- 238000012800 visualization Methods 0.000 title claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
- 238000005259 measurement Methods 0.000 abstract description 17
- 210000000577 adipose tissue Anatomy 0.000 abstract description 13
- 210000003205 muscle Anatomy 0.000 abstract description 11
- 230000009026 tissue transition Effects 0.000 abstract description 3
- 206010025282 Lymphoedema Diseases 0.000 description 32
- 208000002502 lymphedema Diseases 0.000 description 32
- 230000008859 change Effects 0.000 description 11
- 238000012546 transfer Methods 0.000 description 9
- 230000007704 transition Effects 0.000 description 9
- 238000004364 calculation method Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 210000001365 lymphatic vessel Anatomy 0.000 description 7
- 210000003722 extracellular fluid Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000036962 time dependent Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 5
- 229960004657 indocyanine green Drugs 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000004891 communication Methods 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 230000010365 information processing Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 238000012806 monitoring device Methods 0.000 description 3
- 239000000941 radioactive substance Substances 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000002706 hydrostatic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 238000002587 lymphangiography Methods 0.000 description 2
- 238000011271 lymphoscintigraphy Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000003325 tomography Methods 0.000 description 2
- 208000035484 Cellulite Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001593 brown adipocyte Anatomy 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 230000002016 colloidosmotic effect Effects 0.000 description 1
- 238000002247 constant time method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000013135 deep learning Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000003692 lymphatic flow Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000000636 white adipocyte Anatomy 0.000 description 1
Landscapes
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
2 電極バンド
3 ケーブル
Claims (6)
- 使用者の体の周囲に配置される複数の電極を備えた電極バンドを2つ以上有し、前記2つ以上の電極バンドが概ね平行に配置された生体内物質の可視化装置において、
前記複数の電極間に電気信号を印加することで電気的特性を計測する計測手段と、前記計測手段が計測した電気的特性に基づき生体内物質の移動量又は移動方向を推定する移動推定手段とを備えた生体内物質の可視化装置。 - 前記計測手段が計測する電気的特性は、導電率、誘電率、インピーダンス、レジスタンス、リアクタンス、キャパシタンス、アドミタンス、コンダクタンス、サセプタンス及び位相の少なくともいずれかである請求項1記載の生体内物質の可視化装置。
- 少なくとも1つ以上の前記電極バンドが前記体を押圧する機能を有する請求項1または2記載の生体内物質の可視化装置。
- 前記電極バンドを3つ有し、前記3つの電極バンドが概ね平行に配置された請求項1乃至3のいずれかに記載の生体内物質の可視化装置。
- 前記電気信号として周波数の異なる複数の信号を有し、前記生体内物質に応じて周波数を切り替えることを特徴とする請求項1乃至4のいずれかに記載の生体内物質の可視化装置。
- 前記生体内物質が水又はタンパク質である請求項1乃至5のいずれかに記載の生体内物質の可視化装置。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019134646A JP7349129B2 (ja) | 2019-07-22 | 2019-07-22 | 生体内物質の可視化装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019134646A JP7349129B2 (ja) | 2019-07-22 | 2019-07-22 | 生体内物質の可視化装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021016625A true JP2021016625A (ja) | 2021-02-15 |
JP7349129B2 JP7349129B2 (ja) | 2023-09-22 |
Family
ID=74564444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019134646A Active JP7349129B2 (ja) | 2019-07-22 | 2019-07-22 | 生体内物質の可視化装置 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7349129B2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023074734A1 (ja) * | 2021-10-26 | 2023-05-04 | 国立大学法人千葉大学 | マッサージ装置 |
JP7440985B2 (ja) | 2020-10-23 | 2024-02-29 | 北京華睿博視医学影像技術有限公司 | 電気インピーダンスイメージング方法、システム、記憶媒体および電子機器 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003169779A (ja) * | 2001-12-06 | 2003-06-17 | Fukuda Denshi Co Ltd | 脈波伝播速度測定装置 |
JP2006525840A (ja) * | 2003-05-12 | 2006-11-16 | チータ メディカル インコーポレイテッド | 血流および血液量を測定するためのシステム、方法、および装置 |
JP2014525764A (ja) * | 2011-06-10 | 2014-10-02 | コーニンクレッカ フィリップス エヌ ヴェ | 光学形状センシングに伴う動的な制約 |
JP2014204849A (ja) * | 2013-04-12 | 2014-10-30 | トヨタ紡織株式会社 | 生体情報計測装置及び生体情報計測方法 |
JP2015051101A (ja) * | 2013-09-06 | 2015-03-19 | 花王株式会社 | 筋肉量測定装置 |
JP2016538062A (ja) * | 2013-11-28 | 2016-12-08 | ユニヴァーシティ オブ ウェスタン シドニー | 血液量モニタ |
JP2017029487A (ja) * | 2015-08-03 | 2017-02-09 | 国立大学法人 千葉大学 | リンパ浮腫モニタ装置 |
US20190175055A1 (en) * | 2014-11-07 | 2019-06-13 | Samsung Electronics Co., Ltd. | Wrist-type body component measuring apparatus and body component measuring method using the same |
-
2019
- 2019-07-22 JP JP2019134646A patent/JP7349129B2/ja active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003169779A (ja) * | 2001-12-06 | 2003-06-17 | Fukuda Denshi Co Ltd | 脈波伝播速度測定装置 |
JP2006525840A (ja) * | 2003-05-12 | 2006-11-16 | チータ メディカル インコーポレイテッド | 血流および血液量を測定するためのシステム、方法、および装置 |
JP2014525764A (ja) * | 2011-06-10 | 2014-10-02 | コーニンクレッカ フィリップス エヌ ヴェ | 光学形状センシングに伴う動的な制約 |
JP2014204849A (ja) * | 2013-04-12 | 2014-10-30 | トヨタ紡織株式会社 | 生体情報計測装置及び生体情報計測方法 |
JP2015051101A (ja) * | 2013-09-06 | 2015-03-19 | 花王株式会社 | 筋肉量測定装置 |
JP2016538062A (ja) * | 2013-11-28 | 2016-12-08 | ユニヴァーシティ オブ ウェスタン シドニー | 血液量モニタ |
US20190175055A1 (en) * | 2014-11-07 | 2019-06-13 | Samsung Electronics Co., Ltd. | Wrist-type body component measuring apparatus and body component measuring method using the same |
JP2017029487A (ja) * | 2015-08-03 | 2017-02-09 | 国立大学法人 千葉大学 | リンパ浮腫モニタ装置 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7440985B2 (ja) | 2020-10-23 | 2024-02-29 | 北京華睿博視医学影像技術有限公司 | 電気インピーダンスイメージング方法、システム、記憶媒体および電子機器 |
WO2023074734A1 (ja) * | 2021-10-26 | 2023-05-04 | 国立大学法人千葉大学 | マッサージ装置 |
Also Published As
Publication number | Publication date |
---|---|
JP7349129B2 (ja) | 2023-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11612332B2 (en) | Hydration status monitoring | |
Lukaski | Evolution of bioimpedance: a circuitous journey from estimation of physiological function to assessment of body composition and a return to clinical research | |
JP5491362B2 (ja) | 生体インピーダンス方法及び装置 | |
Bracco et al. | Segmental body composition assessed by bioelectrical impedance analysis and DEXA in humans | |
Organ et al. | Segmental bioelectrical impedance analysis: theory and application of a new technique | |
Nuutinen et al. | Validation of a new dielectric device to assess changes of tissue water in skin and subcutaneous fat | |
JP2009511217A (ja) | 身体の機能および状態の電気的測定のための装置およびプロセス | |
Broers et al. | Body composition in dialysis patients: a functional assessment of bioimpedance using different prediction models | |
CA2684324A1 (en) | Monitoring system and probe | |
EP2854633A1 (en) | Method and apparatus for estimating the fluid content of a part of the body of a subject | |
JP7349129B2 (ja) | 生体内物質の可視化装置 | |
Patterson et al. | Measurement of body fluid volume change using multisite impedance measurements | |
Kalodiki et al. | Air plethysmography: the answer in detecting past deep venous thrombosis | |
Codognotto et al. | Influence of localized edema on whole-body and segmental bioelectrical impedance | |
González-Correa | Body composition by bioelectrical impedance analysis | |
Dovancescu et al. | Monitoring thoracic fluid content using bioelectrical impedance spectroscopy and Cole modeling | |
Levin et al. | Use of segmental multifrequency bioimpedance spectroscopy in hemodialysis | |
Anderson et al. | Impedance plethysmography: the origin of electrical impedance changes measured in the human calf | |
Dovancescu et al. | Sensitivity of a wearable bioimpedance monitor to changes in the thoracic fluid content of heart failure patients | |
Cai et al. | Influence of temperature on the distribution of blood in humans as assessed by electrical impedance | |
Tseng et al. | Electrodermal screening of biologically active points for upper gastrointestinal bleeding | |
Агзамходжаев et al. | DIAGNOSTIC ADVANTAGES OF CONTACTLESS BIOIMPEDANESOMETRY | |
Singh et al. | A technical review of various bioelectric impedance methods for health monitoring | |
Khan et al. | MULTI-DIMENSION APPLICATIONS OF BIOELECTRICAL IMPEDANCE ANALYSIS. | |
Yu et al. | The effects of tissue proportions on blood volume change-induced variations using bio-impedance analysis: a simulation study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220525 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230327 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230517 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20230517 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20230517 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230822 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230904 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7349129 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |